A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual ...

GA lesions, which form on the retina due to degeneration of pigment epithelium and photoreceptors, significantly impact daily functioning. This analysis assessed how functional and structural ...

Phase I clinical and pharmacokinetic study of the farnesyl transferase inhibitor BMS-214662 administered intravenously for five consecutive days in patients with advanced malignancies No significant ...